Acusphere Inc.
99 Hayden Avenue
Suite 385
Lexington
Massachusetts
02421
United States
Tel: 617-577-8800
Fax: 978-863-9993
Website: http://www.acusphere.com/
113 articles about Acusphere Inc.
-
Acusphere Inc. Withdraws Its European Marketing Authorization Application For Imagify
8/28/2014
-
Acusphere Inc. Appoints Mark Leuchtenberger as President and CEO
9/17/2013
-
Acusphere Inc. Announces Submission of Marketing Authorisation Application for Imagify in Europe and Start of Procedural Review
10/24/2012
-
Acusphere Inc. Announces Completion of Marketing Authorisation Application for Imagify in Europe; Secures Additional Financing
7/9/2012
-
Acusphere Inc. Stockholders Approve Reverse Stock Split at Special Meeting of Stockholders
1/20/2012
-
Acusphere Inc. Issues Letter to Shareholders
12/19/2011
-
Acusphere Inc. Reaches Special Protocol Assessment Agreement with FDA for Imagify(TM) Phase 3 Placebo-Controlled Trial
6/8/2011
-
Acusphere Inc. Announces Closing of $10 Million Financing to Support Continued Development of Imagify
7/1/2010
-
Acusphere Inc. Issues Letter To Shareholders
3/25/2010
-
Acusphere Inc. CEO to Resign
12/16/2009
-
Acusphere Inc. Announces Change in Management
12/16/2009
-
Acusphere Inc. Issues Letter To Shareholders
10/21/2009
-
Acusphere Inc. Announces Amended Terms of Cephalon, Inc. Agreements
6/25/2009
-
Acusphere Inc. Announces Prepayment of Equipment Loans
5/20/2009
-
Acusphere Inc. Reports Q4 2008 Recent Business Highlights, Business Priorities and Financial Results
4/1/2009
-
Acusphere Inc. Reports Q4 2008 Recent Business Highlights, Business Priorities and Financial Results
4/1/2009
-
Acusphere Inc. Receives Complete Response from FDA
3/12/2009
-
Acusphere Inc. Announces Further Cost Reductions and Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations
3/4/2009
-
Delisting of Securities of Acusphere Inc. From The NASDAQ Stock Market
2/20/2009
-
Acusphere Inc. Announces Change In Imagify Regulatory Strategy and Deferral of Near-Term Contractual Cash Payments
2/18/2009